Effect of weight loss on C3 and C4 components of complement in obese patients

European Journal of Clinical Investigation

Volumn 42, Issue 5, 2012, Pages 503-509

  Hernández Mijares, Antonio ^a,b   Bañuls, Celia ^a   Bellod, Lorena ^a   Jover, Ana ^a   Solá, Eva ^a   Morillas, Carlos ^a   Víctor, Víctor M ^a,b   Rocha, Milagros ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Complement factor 3; Morbid obesity; Very low calorie diet; Weight loss

Indexed keywords

APOLIPOPROTEIN A1; BICARBONATE; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHAQUALONE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; CALORIC RESTRICTION; COMPLEMENT C3; COMPLEMENT C4; DIET, REDUCING; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; TIME FACTORS; WEIGHT LOSS;

EID: 84859733680     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02606.x     Document Type: Article

References (38)

1. Kopelman P. Health risks associated with overweight and obesity. Obes Rev 2007;8:13-7.
2. Hermsdorff HH, Zulet MA, Abete I, Martínez JA. Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine 2009;36:445-51.
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med 2001;134:1-11.
5. Saris WH. Very-low-calorie diets and sustained weight loss. Obes Res 2001;9:295S-301S.
6. Unsworth DJ. Complement deficiency and disease. J Clin Pathol 2008;61:1013-7.
7. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:1-8.
8. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008;28:1654-9.
9. Engström G, Hedblad B, Berglund G, Janzon L, Lindgärde F. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens 2007;21:276-82.
10. Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgärde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 2005;54:570-5.
11. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 2000;21:1081-90.
12. Haskard DO, Boyle JJ, Mason JC. The role of complement in atherosclerosis. Curr Opin Lipidol 2008;19:478-82.
13. Gabrielsson BG, Johansson JM, Lönn M, Jernås M, Olbers T, Peltonen M et al. High expression of complement components in omental adipose tissue in obese men. Obes Res 2003;11:699-708.
14. Hernández-Mijares A, Jarabo-Bueno MM, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero ML. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes 2007;31:927-32.
15. Peake PW, Kriketos AD, Campbell LV, Charlesworth JA. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. Int J Obes 2005;29:429-35.
16. Muscari A, Sbano D, Bastagli L, Poggiopollini G, Tomassetti V, Forti P et al. Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. Int J Cardiol 2005;100:217-23.
17. Pomeroy C, Mitchell J, Eckert E, Raymond N, Crosby R, Dalmasso AP. Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity. Clin Exp Immunol 1997;108:507-15.
18. Salas-Salvadó J, Rubio MA, Barbany M, Moreno B; Grupo Colaborativo de la SEEDO. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria. Med Clin (Barc) 2007;128:184-96.
19. Allan CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
20. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
21. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alphacyclodextrin. Clin Chem 1995;41:717-23.
22. Friedewald WT, Levy RI, Fredricson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Sternberg JC. A rate nephelometer for measuring specific proteins by inmunoprecipitation reactions. Clin Chem 1977;23:1456-64.
24. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633-8.
25. Walton C, Lees B, Crook D, Worthington M, Godsland IF, Stevenson JC. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. Am J Med 1995;99:459-64.
26. Nguyen TT, Hernández Mijares A, Johnson CM, Jensen MD. Postprandial leg and splanchnic fatty acid metabolism in nonobese men and women. Am J Physiol 1996;271:E965-72.
27. Hernández Mijares A, Morillas Ariño C, Royo Taberner R, Solá Izquierdo E, Garzón Pastor S, Martínez Triguero ML et al. Malnutrition evaluation in obese patients of both sexes on a very low caloric content diet. Rev Clin Esp 2004;204:410-4.
28. Toubro S, Astrup A. Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake. BMJ 1997;314:29-34.
29. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988;319:1173-9.
30. Sakçak I, Avşar MF, Hamamci{dotless} EO, Bostanoǧlu S, Soni{dotless}şi{dotless}k M, Bostanoǧlu A et al. Comparison of early and late changes in immunoglobulins and acute phase reactants after laparoscopic adjustable gastric banding in patients with morbid obesity. Obes Surg 2010;20:610-5.
31. Solá E, Jover A, López-Ruiz A, Jarabo M, Vayá A, Morillas C et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg 2009;19:571-6.
32. Solá E, Vayá A, Contreras T, Falcó C, Corella D, Hernández A et al. Effect of a hypocaloric diet on lipids and rheological profile in subjects with severe and morbid obesity. A follow-up study. Clin Hemorheol Microcirc 2004;30:419-22.
33. Shoji T, Nishizawa Y, Koyama H, Hagiwara S, Aratani H, Sasao K et al. High-density-lipoprotein metabolism during a very-low-calorie diet. Am J Clin Nutr 1992;56(Suppl 1):297S-8S.
34. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56:320-8.
35. Vázquez LA, Pazos F, Berrazueta JR, Fernández-Escalante C, García-Unzueta MT, Freijanes J et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005;90:316-22.
36. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 2009;50:5818-27.
37. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992;267:12736-41.
38. Hanusch-Enserer U, Cauza E, Spak M, Dunky A, Rosen HR, Wolf H et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 2003;27:355-61.